Vaccine-maker Kizzmekia Corbett, who helped develop Moderna's vaccine at the NIH, said "don't let the perfect get in the way ...

A stunning new study offers early evidence that COVID-19 vaccines might have a secret superpower: a precisely timed mRNA shot could help many cancer patients live longer.

Moderna (NASDAQ:MRNA) updated data from a Phase 4 clinical trial for its redesigned COVID-19 vaccine, noting that the mRNA-based shot branded as mNEXSPIKE led to more than a 15-fold increase in ...

Moderna lowered the top end of its 2025 revenue forecast by $200 million on Thursday, citing weaker-than-expected sales of ...

Analysts are expecting Moderna to report revenue of $880 million in the third quarter, according to FactSet. The consensus ...

Despite quarterly revenue totals that were nearly cut in half compared to the same period last year, Moderna still expects to ...

Shares in Moderna and BioNTech have imploded since their 2021 peaks, shaving billions of dollars from their founders’ fortunes. Growing anti-vax hysteria and RFK Jr.’s FDA will likely make the ...

U.S. health advisers said Thursday that some Americans who received Moderna's COVID-19 vaccine at least six months ago should get a half-dose booster to rev up protection against the coronavirus. The ...

COVID-19 mRNA vaccines may enhance the effects of immunotherapy drugs in cancer patients, potentially improving survival rates.

Delaware says COVID-19 vaccines are available at state clinics, regardless of insurance status. But only 2 clinics carried ...